Metabolic Modulators
This category covers peptides and related signaling compounds studied for their influence on metabolic regulation, mitochondrial function, and energy utilization within cells. Research often focuses on pathways affecting glucose metabolism, lipid oxidation, thermogenesis, and mitochondrial efficiency. These compounds are frequently explored in contexts involving metabolic flexibility, body composition regulation, energy expenditure, and cellular energy signaling networks.
5-Amino-1MQ
No human dataA small molecule, not a peptide, that blocks an enzyme called NNMT. The mouse data are consistent and interesting. There are no human trials at all.
human 0 · sources 6
AOD-9604
Early human dataA growth-hormone fragment marketed for fat loss. It was developed as an actual obesity drug, the rigorous trials didn't deliver, it's approved nowhere, and it's banned in sport.
human 3 · sources 5
Kisspeptin-10
Early human dataKisspeptin-10 is a short signalling peptide that acts upstream of the reproductive hormone axis. The human record is small and acute, and kisspeptin is prohibited in tested sport.
human 2 · sources 5
NAD+
Early human dataNAD+ is a cellular redox and energy-metabolism topic tied to mitochondrial biology, aging research, and human precursor studies.
human 4 · sources 9
Retatrutide
Controlled human trialsRetatrutide is an investigational triple GIP, GLP-1 and glucagon agonist with completed Phase 3 obesity data, the strongest human evidence in this library. Not approved; filing expected 2027.
human 3 · sources 5
SLU-PP-332
No human dataSLU-PP-332 is an ERR agonist research compound discussed around exercise-mimetic biology, mitochondrial signaling, and metabolic models.
human 0 · sources 5
Tesamorelin
Approved medicineTesamorelin is a GHRH analog with approved medical-use context and endocrine-metabolic relevance that requires precise framing.
human 1 · sources 6